Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
Akoya Biosciences, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||
| Equity | Common Stock, $0.00001 par value per share | Other | 1,871,205 | (2) | $ | 10.09 | (4) | $ | 18,880,458.45 | $ 92.70 per $ 1,000,000 | $ | 1,750.22 | ||||||||||
| Equity | Common Stock, $0.00001 par value per share | Other | 187,120 | (3) | $ | 8.58 | (5) | $ | 1,605,489.60 | $ 92.70 per $ 1,000,000 | $ | 148.83 | ||||||||||
| Total Offering Amounts | $ | 20,485,948.05 | $ | 1,899.05 | ||||||||||||||||||
| Total Fee Offsets | - | |||||||||||||||||||||
| Net Fee Due | $ | 1,899.05 | ||||||||||||||||||||
| (1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s Common Stock (the “Common Stock”) that become issuable under the 2021 Equity Incentive Plan (the “2021 Plan”) and the 2021 Employee Stock Purchase Plan (the “2021 ESPP”) by reason of any stock dividend, stock split, recapitalization or other similar transaction. |
| (2) | Represents 1,871,205 shares of Common Stock that became available for issuance on January 1, 2022 under the 2021 Plan pursuant to an evergreen provision of the 2021 Plan. Pursuant to such provision, an additional number of shares will automatically be added to the shares authorized for issuance under the 2021 Plan on January 1 of each calendar year, from January 1, 2022 through January 1, 2030. The number of shares added each year will be equal to: (a) 5% of the total number of shares of common stock issued and outstanding on December 31 of the preceding calendar year; or (b) such lesser number of shares of Common Stock as is determined by the Registrant’s board of directors (the “Board”) for the applicable year. |
| (3) | Represents 187,120 shares of Common Stock that became available for issuance on January 1, 2022 under the 2021 ESPP pursuant to an evergreen provision of the 2021 ESPP. The 2021 ESPP provides that an additional number of shares will automatically be added to the shares authorized for issuance under the 2021 ESPP on January 1 of each calendar year, from January 1, 2022 through January 1, 2030. The number of shares of Common Stock added each year will be equal to the lesser of: (a) 0.5% of the total number of shares of common stock issued and outstanding on December 31 of the preceding calendar year; or (b) a lesser number of shares of Common Stock as is determined by the Board for the applicable year. |
| (4) | Estimated solely for the purpose of computing the registration fee pursuant to Rule 457 under the Securities Act and based on the average of the high and low prices per share of the Registrant’s common stock on March 8, 2022 as reported on the NASDAQ Global Select Market. |
| (5) | Estimated solely for the purpose of computing the registration fee pursuant to Rule 457 under the Securities Act and based on the average of the high and low sales prices per share of the Registrant’s common stock on March 8, 2022 as reported on the NASDAQ Global Select Market, multiplied by 85%. Pursuant to the 2021 ESPP, the purchase price of a share is 85% of the fair market value of the lower of the Registrant’s common stock on the Offering Date or the Purchase Date (as such terms are defined in the 2021 ESPP). |
